| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ion channel regulator activity | 5.40e-04 | 162 | 20 | 3 | GO:0099106 | |
| GeneOntologyMolecularFunction | channel regulator activity | 6.65e-04 | 174 | 20 | 3 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 6.99e-04 | 177 | 20 | 3 | GO:0141108 | |
| MousePheno | abnormal behavioral response to alcohol | 2.45e-06 | 24 | 16 | 3 | MP:0020157 | |
| MousePheno | impaired behavioral response to addictive substance | 1.70e-05 | 45 | 16 | 3 | MP:0009750 | |
| MousePheno | impaired behavioral response to alcohol | 5.50e-05 | 10 | 16 | 2 | MP:0009755 | |
| MousePheno | impaired behavioral response to xenobiotic | 1.07e-04 | 83 | 16 | 3 | MP:0009747 | |
| MousePheno | increased alcohol consumption | 1.28e-04 | 15 | 16 | 2 | MP:0003545 | |
| MousePheno | abnormal behavioral response to addictive substance | 1.97e-04 | 102 | 16 | 3 | MP:0009748 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 2.45e-03 | 69 | 20 | 2 | IPR020636 | |
| Domain | Ser/Thr_kinase_AS | 6.20e-03 | 357 | 20 | 3 | IPR008271 | |
| Domain | S_TKc | 6.30e-03 | 359 | 20 | 3 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 6.44e-03 | 362 | 20 | 3 | PS00108 | |
| Domain | Protein_kinase_ATP_BS | 7.31e-03 | 379 | 20 | 3 | IPR017441 | |
| Domain | Pkinase | 7.42e-03 | 381 | 20 | 3 | PF00069 | |
| Domain | PROTEIN_KINASE_ATP | 1.23e-02 | 459 | 20 | 3 | PS00107 | |
| Domain | Prot_kinase_dom | 1.46e-02 | 489 | 20 | 3 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.49e-02 | 493 | 20 | 3 | PS50011 | |
| Pathway | WP_SEROTONIN_AND_ANXIETY | 1.42e-04 | 17 | 15 | 2 | MM15861 | |
| Pathway | WP_SEROTONIN_AND_ANXIETY | 1.42e-04 | 17 | 15 | 2 | M39511 | |
| Pathway | PID_P38_MKK3_6PATHWAY | 3.38e-04 | 26 | 15 | 2 | M20 | |
| Pubmed | 5.93e-05 | 20 | 20 | 2 | 30596474 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.34e-04 | 1105 | 20 | 5 | 35748872 | |
| Pubmed | 4.42e-04 | 54 | 20 | 2 | 15163632 | ||
| Pubmed | 5.10e-04 | 276 | 20 | 3 | 28319085 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.57e-03 | 1192 | 20 | 4 | chr19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p11 | 2.02e-03 | 153 | 20 | 2 | chr11p11 | |
| GeneFamily | RNA binding motif containing | 1.31e-02 | 213 | 15 | 2 | 725 | |
| GeneFamily | Ankyrin repeat domain containing | 1.67e-02 | 242 | 15 | 2 | 403 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 1.61e-05 | 438 | 20 | 5 | M1954 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 1.64e-05 | 440 | 20 | 5 | MM832 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | 1.21e-04 | 345 | 20 | 4 | M2009 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | 1.24e-04 | 347 | 20 | 4 | MM860 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.81e-05 | 160 | 20 | 3 | c2b5fadb4bac17fafc08831f6d3f4ff96ada7e70 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.56e-05 | 168 | 20 | 3 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor-MUC5AC+ASCL1+_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.76e-05 | 170 | 20 | 3 | d6e244725b21592c6056b9c443aac090f1eae836 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 6.07e-05 | 173 | 20 | 3 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-2|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 6.39e-05 | 176 | 20 | 3 | 179b1778e8f6c4cd777cec971960211e7ba5d84a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 180 | 20 | 3 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 184 | 20 | 3 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 186 | 20 | 3 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 188 | 20 | 3 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 189 | 20 | 3 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.14e-05 | 191 | 20 | 3 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 193 | 20 | 3 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-05 | 195 | 20 | 3 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 195 | 20 | 3 | d8fa96c8f14bd088c3f8bd14f894a2c5b7ad46a7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.79e-05 | 196 | 20 | 3 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| ToppCell | (5)_Dendritic_cell-(54)_pDC|(5)_Dendritic_cell / shred on Cell_type and subtype | 9.06e-05 | 198 | 20 | 3 | fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.06e-05 | 198 | 20 | 3 | 60d8d3bbd754ffde41c50013d822667b185a9751 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.19e-05 | 199 | 20 | 3 | 1029f3458b7fda464aa0e7ef06e081e2618c1388 | |
| ToppCell | mLN-(5)_Dendritic_cell-(54)_pDC|mLN / shred on region, Cell_type, and subtype | 9.19e-05 | 199 | 20 | 3 | 1e738219784a446ee8b0ddeb408e0050e1929e60 | |
| ToppCell | mLN-Dendritic_cell-pDC|mLN / Region, Cell class and subclass | 9.19e-05 | 199 | 20 | 3 | 54f1abb57af7bf8a8b82a38b933f257df3b5d8df | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal-PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.19e-05 | 199 | 20 | 3 | 8a04398653a1794921d73a6a950c1fb6fdf68c85 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 9.33e-05 | 200 | 20 | 3 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | 8943278190f42016ee914e584d1b6b9aeaf7c73f | |
| ToppCell | mLN-Dendritic_cell-pDC|Dendritic_cell / Region, Cell class and subclass | 9.33e-05 | 200 | 20 | 3 | 10ae1ac8a98346320a92e855aebb3a7109f0ab9b | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | ea52df18400550b65de142d03b3b0963436e03d9 | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 9.75e-05 | 203 | 20 | 3 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Sla_(Layer6a)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.46e-04 | 52 | 20 | 2 | 14971277db09343d668e4f5a82ca2b6a92326251 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Sla_(Layer6a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.46e-04 | 52 | 20 | 2 | c134eb63bd1969af2af7f8de5989e19063533865 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Nefm_(iSPN)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.10e-04 | 82 | 20 | 2 | d5f8f5aad7e41d1151772d1ca2415a9d0722c98a | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Nefm_(iSPN)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.10e-04 | 82 | 20 | 2 | 045e702e7cb208107e8529a35f0cbbcf75b20786 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-03 | 112 | 20 | 2 | 32c6ab8e9b71c6c3df7e3e119b88e6ad1b895d50 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.15e-03 | 113 | 20 | 2 | b795a0c65114b3c0758fe3720e8a80247f900971 | |
| ToppCell | COVID-19_Mild-Myeloid_G-immature_Neutrophil|COVID-19_Mild / Disease group, lineage and cell class | 1.15e-03 | 113 | 20 | 2 | fc3417c379f871a4aec3edef953baaa00755c472 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-03 | 114 | 20 | 2 | 613714fd15ad6d553e63d8538ad53bc1ded6bd6c | |
| ToppCell | COVID-19_Mild-immature_Neutrophil-|COVID-19_Mild / Disease condition and Cell class | 1.36e-03 | 123 | 20 | 2 | 5f19b0e32509bedeb9ac6c74ac7a20750798da5e | |
| ToppCell | COVID-19_Mild-immature_Neutrophil|COVID-19_Mild / Disease condition and Cell class | 1.36e-03 | 123 | 20 | 2 | a6670825fd8d9f9a0111a7b68598c764c99abb0d | |
| ToppCell | mild-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.48e-03 | 128 | 20 | 2 | 7a0a7af930e9050d473390fe9827f96fd597f790 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.54e-03 | 131 | 20 | 2 | 5b29f0dc449b9fff5e8bf6365080168f31b7e268 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.57e-03 | 132 | 20 | 2 | 4e37400ae7375e6986f060234c373194603346f8 | |
| ToppCell | mild-Myeloid-CD14_Monocytes_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.62e-03 | 134 | 20 | 2 | 8ba1f8d0af63bb7a802a002e72fe181b203cb451 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.62e-03 | 134 | 20 | 2 | b5466759285b4973850afb2e1be7c1d25f1c7927 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-03 | 135 | 20 | 2 | 7b456fa9a5f5ce58976a8f1fad18c0f96a096930 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-pDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-03 | 135 | 20 | 2 | 0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.69e-03 | 137 | 20 | 2 | 576ca865b8e8e59d23aa35cb9dafee0cf7d38e6a | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-03 | 139 | 20 | 2 | 4efab4421e3448880a1dcf981f6a65131b038010 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-03 | 139 | 20 | 2 | 39f3c28f89c37bb8cc049c56d2948ea906fb3d86 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.79e-03 | 141 | 20 | 2 | 73b3e967357cba7585d97ec9e9d48d3e94ebe31e | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.81e-03 | 142 | 20 | 2 | 77fd145c1c500d580f70ac4e54c3fd879ecf0ab3 | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.89e-03 | 145 | 20 | 2 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.91e-03 | 146 | 20 | 2 | bee5074c29b132180d35f57d307e342efa9b8cd1 | |
| ToppCell | Tuft-tuft-3|World / Class top | 1.96e-03 | 148 | 20 | 2 | f4f59b46a79fc9aa4c5d330a7b37b1a34a6d71cc | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.02e-03 | 150 | 20 | 2 | c922dbb4c9c12ccf08bd5f6168b20606c605d052 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-03 | 151 | 20 | 2 | 22afd8201eff8471da3456be065f2790de5e4bfe | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-03 | 151 | 20 | 2 | 2dc132895609e4efe17954e31f53d9c1ccf256ef | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-pDC_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-03 | 151 | 20 | 2 | 8ffd71d847fe1aeebe7f43c4b6ca73efb19d6041 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-03 | 152 | 20 | 2 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-03 | 152 | 20 | 2 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.10e-03 | 153 | 20 | 2 | a156710217ef07c07a80ca6504fa0784d86380fa | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-03 | 154 | 20 | 2 | 1f8d127b657976656e4ec292f26d619943533b86 | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_Naive|URO / Disease, Lineage and Cell Type | 2.12e-03 | 154 | 20 | 2 | 6c214ad5cbbfa8bab3f76b593cb598dfb914b566 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.12e-03 | 154 | 20 | 2 | 1ad4152a3e4bf5912954235fe21c2447e99f3de7 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.12e-03 | 154 | 20 | 2 | 3c9d38709f507e91ec3bcc6184cbbfa9b1250128 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.18e-03 | 156 | 20 | 2 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-03 | 157 | 20 | 2 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | Control-Lymphocyte-T_NK-dnT|Control / Disease, Lineage and Cell Type | 2.23e-03 | 158 | 20 | 2 | 7a2fad6426549d910834debfe5e102fe2ab5976d | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-03 | 159 | 20 | 2 | f0611a7bf15e2f7dfe828dd247650a30b3d6d44d | |
| ToppCell | severe_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 2.26e-03 | 159 | 20 | 2 | e1c48c4ceda116826819ff9adeed7bad6a58844d | |
| ToppCell | severe_COVID-19-pDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.26e-03 | 159 | 20 | 2 | ea5088d27e42b8850455764d53b757ea8d8f14bc | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.26e-03 | 159 | 20 | 2 | 141c3ed35c7d11fcaec4acd9cb37104cc259db25 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 2.26e-03 | 159 | 20 | 2 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.29e-03 | 160 | 20 | 2 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-03 | 160 | 20 | 2 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.29e-03 | 160 | 20 | 2 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tregs|Liver / Manually curated celltypes from each tissue | 2.32e-03 | 161 | 20 | 2 | e0fd0c5f72d6a2900827e7bc2608ce3b8df5686b | |
| ToppCell | severe-Myeloid-pDC|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.32e-03 | 161 | 20 | 2 | 9e8e8ac11f7fb8c8697357c21034b613f191db2b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-03 | 161 | 20 | 2 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | LAM-Lymphoid-pDC|LAM / Condition, Lineage and Cell class | 2.32e-03 | 161 | 20 | 2 | bb5b44713e4da4406cdaa79dcf2aa9f97e3cf75a | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-03 | 161 | 20 | 2 | d02f8c01b26158a06e109eb603b0fe76372ec983 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 162 | 20 | 2 | 25323785dd33337bcefd05958a4a1a208a9ceb04 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.35e-03 | 162 | 20 | 2 | afffecc6c504930554aafc12c5bffa53e3c5b016 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 162 | 20 | 2 | 3dc39db0d5f6f3d7bcc312a6bce7aaeb914138d1 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-03 | 162 | 20 | 2 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 162 | 20 | 2 | 0a7138266054ea5954649c8b61ef93905d56b068 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-03 | 162 | 20 | 2 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.35e-03 | 162 | 20 | 2 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-03 | 163 | 20 | 2 | ae9c5eb19657ea94b7f2357cbc8679acd697b8fe | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.37e-03 | 163 | 20 | 2 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.37e-03 | 163 | 20 | 2 | db6b7ce6f7221bb73c5e650ac51cdd5d7ef00675 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.37e-03 | 163 | 20 | 2 | 2913ccdd4613472cd82077d4993e1d9f8b223398 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.37e-03 | 163 | 20 | 2 | b589ff57d58dcb215ee3b5a10d81f43e5752a196 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-03 | 163 | 20 | 2 | 8509b87748ec460992ae6cedbb155e1c6f6e2e48 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-03 | 163 | 20 | 2 | e04de78a52cc886623689a913f7852200a77605b | |
| ToppCell | BAL-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 2.37e-03 | 163 | 20 | 2 | 7047d3ba847930f42a6d5f71e18d49f3071c6409 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|metastatic_Brain / Location, Cell class and cell subclass | 2.40e-03 | 164 | 20 | 2 | 06db4cc064f0765c481ce880207823872c27bfa9 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-3|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.40e-03 | 164 | 20 | 2 | 201aee6387e69f918d87fa87d9b5b2ab3b305f61 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.40e-03 | 164 | 20 | 2 | f0499e6c1b17c4df72b18b294e3b53ef723da2ac | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-03 | 164 | 20 | 2 | d2218d50e0e2d19f919dcb460b3840687c082810 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.43e-03 | 165 | 20 | 2 | e2a70dd5870fe8708bf630ed3e6eb3f295df0cdf | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.43e-03 | 165 | 20 | 2 | d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-03 | 166 | 20 | 2 | ec7bd549bda5f18aca8aebce5ba479a81abbbeda | |
| Disease | Marijuana Abuse | 1.51e-04 | 30 | 18 | 2 | C0024809 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.82e-03 | 152 | 18 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | 5.93e-03 | 619 | 18 | 3 | EFO_0003923, EFO_0004531 | |
| Disease | metabolic syndrome | 6.51e-03 | 200 | 18 | 2 | EFO_0000195 | |
| Disease | body fat distribution | 6.64e-03 | 202 | 18 | 2 | EFO_0004341 | |
| Disease | Schizophrenia | 1.56e-02 | 883 | 18 | 3 | C0036341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DADAPARGPPAPPEP | 161 | Q9BXJ3 | |
| PPGDACDIPPPFPNL | 1471 | Q9Y6X6 | |
| EPPPADSPATAPGPD | 421 | Q6PJ61 | |
| APEPDCGDPPPVAPS | 51 | P52848 | |
| PRLPQDPCGPDCAPP | 251 | P21917 | |
| DPCGPDCAPPAPGLP | 256 | P21917 | |
| PQDPCGPDCAPPAPG | 286 | P21917 | |
| PPNPAPAAPAPGEDD | 81 | Q9NR34 | |
| APDPAPEPDPASAPA | 426 | O95487 | |
| PEAEGPLPCPSPAPF | 426 | Q13554 | |
| DPGDGCPSPDIPPEP | 916 | Q9UL54 | |
| PGPDPAADPAADPCP | 11 | Q9H6T0 | |
| PAADLDPPPGEPPAA | 271 | Q7Z7L8 | |
| CPDPLDGDPNSRPPP | 21 | Q8NER1 | |
| LAGEPAPPAPAPPED | 41 | Q8WXF1 | |
| PPGACPAPARSPEPA | 161 | A6NIX2 | |
| EDKAGCPPRPHPPPA | 351 | Q9Y2Y4 | |
| PGPCSEAPAPELPAP | 791 | O75385 | |
| PPGEPPAPGTCDPAF | 271 | A6NJT0 | |
| DSPPGRPEDCAPPPA | 256 | Q5T230 | |
| RPPDPNPDPDPHGCA | 306 | Q2I0M4 | |
| PGAPEPPGPFPCSEC | 476 | P28698 |